Cargando…

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP

Oncolytic viruses are currently tested as a novel platform for cancer therapy. These viruses preferentially replicate in and kill malignant cells. Due to their microbial origin, treatment with oncolytic viruses naturally results in anti-viral responses and general immune activation. Consequently, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vijver, Saskia V., Danklmaier, Sarah, Pipperger, Lisa, Gronauer, Raphael, Floriani, Gabriel, Hackl, Hubert, Das, Krishna, Wollmann, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893851/ https://www.ncbi.nlm.nih.gov/pubmed/36741416 http://dx.doi.org/10.3389/fimmu.2022.1100730

Ejemplares similares

The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma
por: Kimpel, Janine, et al.
Publicado: (2018)

Oncolytic activity of the rhabdovirus VSV‐GP against prostate cancer
por: Urbiola, Carles, et al.
Publicado: (2018)

The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer
por: Schreiber, Liesa-Marie, et al.
Publicado: (2019)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
por: Dold, Catherine, et al.
Publicado: (2016)

Predicting MHC class I epitopes in large datasets
por: Roomp, Kirsten, et al.
Publicado: (2010)

The viral vector vaccine VSV-GP boosts immune response upon repeated applications
por: Tober, R, et al.
Publicado: (2012)

Single-step rapid chromatographic purification and characterization of clinical stage oncolytic VSV-GP
por: Gautam, Saurabh, et al.
Publicado: (2022)

Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation
por: Li, Ge, et al.
Publicado: (2021)

Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
por: de Wit, Emmie, et al.
Publicado: (2015)

MIO: microRNA target analysis system for immuno-oncology
por: Monfort-Lanzas, Pablo, et al.
Publicado: (2022)

NetCTLpan: pan-specific MHC class I pathway epitope predictions
por: Stranzl, Thomas, et al.
Publicado: (2010)

HLA-DO as the Optimizer of Epitope Selection for MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Computational mining of MHC class II epitopes for the development of universal immunogenic proteins
por: Saylor, Kyle, et al.
Publicado: (2022)

Positive Role of the MHC Class-I Antigen Presentation Regulator m04/gp34 of Murine Cytomegalovirus in Antiviral Protection by CD8 T Cells
por: Becker, Sara, et al.
Publicado: (2020)

Structural Analysis and Epitope Prediction of MHC Class-1-Chain Related Protein-A for Cancer Vaccine Development
por: Adekiya, Tayo Alex, et al.
Publicado: (2017)

To B or Not to B: Mechanisms of Protection Conferred by rVSV-EBOV-GP and the Roles of Innate and Adaptive Immunity
por: Pinski, Amanda N., et al.
Publicado: (2020)

Nonclinical pharmacokinetics and biodistribution of VSV-GP using methods to decouple input drug disposition and viral replication
por: Dambra, Richard, et al.
Publicado: (2022)

An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes
Publicado: (1988)

GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes
por: Cai, Ruikun, et al.
Publicado: (2012)

Towards Universal Structure-Based Prediction of Class II MHC Epitopes for Diverse Allotypes
por: Bordner, Andrew J.
Publicado: (2010)

Endogenous Antigen Presentation of MHC Class II Epitopes through Non-Autophagic Pathways
por: Leung, Carol S. K.
Publicado: (2015)

A combination of epitope prediction and molecular docking allows for good identification of MHC class I restricted T-cell epitopes
por: Zhang, Xue Wu
Publicado: (2013)

In Silico Analyses, Experimental Verification and Application in DNA Vaccines of Ebolavirus GP-Derived pan-MHC-II-Restricted Epitopes
por: Zhang, Junqi, et al.
Publicado: (2023)

Murine cytomegalovirus degrades MHC class II to colonize the salivary glands
por: Yunis, Joseph, et al.
Publicado: (2018)

Recombinant Sudan virus and evaluation of humoral cross-reactivity between Ebola and Sudan virus glycoproteins after infection or rVSV-ΔG-ZEBOV-GP vaccination
por: Kainulainen, Markus H., et al.
Publicado: (2023)

Correction: GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes
por: Cai, Ruikun, et al.
Publicado: (2012)

Folding of Matrix Metalloproteinase-2 Prevents Endogenous Generation of MHC Class-I Restricted Epitope
por: Renaud, Virginie, et al.
Publicado: (2010)

IL-33 promotes MHC class II expression in murine mast cells
por: Ito, Tomonobu, et al.
Publicado: (2015)

A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018)

Epitopes associated with MHC restriction site of T cells. III. I-J epitope on MHC-restricted T helper cells
Publicado: (1987)

Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses
por: Perdiguero, Beatriz, et al.
Publicado: (2019)

MHC Class I Bound to an Immunodominant Theileria parva Epitope Demonstrates Unconventional Presentation to T Cell Receptors
por: Macdonald, Isabel K., et al.
Publicado: (2010)

Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system
por: Paul, Sinu, et al.
Publicado: (2020)

Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol
por: Ochoa, Rodrigo, et al.
Publicado: (2022)

Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas
Publicado: (1986)

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
por: Agallou, Maria, et al.
Publicado: (2014)

Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
por: Qiu, Xiangguo, et al.
Publicado: (2009)

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo
por: Hoff, Nicole A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6gj25lugle8ufq06ahv8bj4ufk